The global antigout drug market is anticipated to grow at a significant CAGR during the forecast period. Antigout drugs are used to treat gout, a most common form of inflammatory arthritis. The gout is caused owing to high uric acid levels in the blood due to hyperuricemia which results in the formation of monosodium urate crystals. The major factor for the growth of the market is the increasing prevalence of gout across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/antigout-drug-market
According to the National Center for Biotechnology Information (NCBI), an estimated 1% to 2% of the population is affected by gout globally. Additionally, men are more likely to get it than women with an estimated five times more in men. Furthermore, gout mostly occurs in men aged 40 and above while it usually only affects women after menopause. Hence, the increasing prevalence of gout is in turn driving the growth of the market during the forecast period.
Some major players in the market include Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2019, Unichem Pharmaceuticals (USA), Inc. announced the launch of Allopurinol Tablets. Allopurinol Tablets is the generic version of Zyloprim of Casper Pharma LLC., and is used for the management of patients with signs and symptoms of primary or secondary gout.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antigout Drug Market Report by Segment
By Type
- Febuxostat
- Benzbromarone
- Allopurinol
- Colchicine
By Application
- Acute Gout
- Chronic Gout
A full report of Antigout Drug Market is available at: https://www.omrglobal.com/industry-reports/antigout-drug-market
Antigout Drug Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
